Drug intelligence / Profile preview

flumetasone pivalate + clioquinol

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Topical (otic, Ear Drops)
01

Overview

Flumetasone pivalate + clioquinol is a fixed-dose ear drop combination of a synthetic difluorinated glucocorticoid (flumetasone pivalate) and a halogenated hydroxyquinoline derivative (clioquinol). Flumetasone pivalate acts as a potent topical anti-inflammatory, anti-allergic, and vasoconstrictive corticosteroid, providing rapid relief of inflammatory symptoms such as pruritus, redness, and swelling. Clioquinol exhibits broad-spectrum antibacterial and antifungal (antimycotic) activity, especially against common otitis externa pathogens including Gram-positive bacteria (notably Staphylococci), certain Gram-negative bacteria, and dermatophyte and yeast fungi (such as Candida, Microsporum, Trichophyton). This combination is indicated for the treatment of otitis externa, otomycosis, and eczema of the external auditory canal with suspected or confirmed secondary infection[1][4][5][7][9]. The medication is applied directly into the external ear canal and is not recommended for children under 2 years.

Brand names
Locacorten-VioformLocorten-VioformLocortenLocacorten
Other names
flumetasone/clioquinolflumetasone and clioquinol ear drops
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on flumetasone pivalate + clioquinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flumetasone pivalate + clioquinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call